a useful msarkser in patients with lung adenocarcinoma.

The expression rate of Ki-67 was relatively high in small cell lung cancer without any prognostic significance.

p53 and Ki-67, but not bcl-2, cyclin D1 or HER-2 may have roles in the process of tumor genesis in non-small cell lung carcinoma

Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer

MCM7 is a more reliable marker than MCM2 or Ki-67 in lung adenocarcinomas

high expression is associated with post-operative recurrence of lung adenocarcinomas

Report correlation of the standardized uptake value in FDG-PET with the expression level of Ki-67 antigen in resected non-small cell lung cancers.

The high expression of CAIX in non-small cell lung cancer tissues is correlated with VEGF level but not with Ki67 level.

The differential expression of DUSP6 correlated with Ki-67 index, suggesting that DUSP6 plays an important role in cancer resistance in different subtypes of non-small cell lung carcinoma.

Ki-67 labeling index after video-assisted thoracoscopic surgery segmentectomy was a prognostic factor of disease-free survival in stage I non-small cell lung cancer.

Ki-67, but not proliferating cell nuclear antigen, has a role in poor disease free survival in patients with adenocarcinoma of the lung

These findings do not provide best evidence for the routine use of Ki-67 index to prognosticate overall short-term survival in patients with pulmonary carcinoid tumors.

A predictive impact of ki-67 to treatment in non-small cell lung cancer remains unclear. [review]

Treg cell level was related to Ki-67 expression and immune status in non-small cell lung cancer patients.

Our data support Ki67 evaluation to estimate non-small-cell lung cancer (NSCLC) patients' prognosis, particularly for adenocarcinoma.

High-grade cell proliferation, as measured by Ki-67 labeling index, significantly correlated with an tumor infiltration pattern that indicated a more aggressive lung squamous cell carcinoma.

Combination of Ki-67 expression and CT value determination was useful for the classification of differentiation and metastatic or proliferative potential of peripheral lung adenocarcinoma.

Ki-67 expression level failed to have a markedly significant impact on survival in patients with extensive-stage small cell lung cancer

KI-67 expression correlates with SATB1 expression in non-small cell lung carcinoma.

Ki-67 levels correlate with neoplasm histologic stage and grade and predict long-term recurrence in pulmonary carcinoid tumors.

Correlation between Skip N2 Metastases and SUVmax, Long Diameter of tumor, and Ki67 expression in Patients with Non-Small-Cell lung cancer.